Prognostic factors in patients with carcinoma in situ treated with intravesical bacille Calmette-Guérin

By Andius Patrik   Damm Ole   Holmäng Sten  

Scandinavian Journal of Urology and Nephrology, Vol. 38, Iss. 4, 2004-09 ,pp. : 285-290

Informa Healthcare

Access to resources Recommend Favorite

Oral bropirimine immunotherapy of bladder carcinoma in situ after prior intravesical bacille Calmette-Guerin

By Sarosdy M.F.   Manyak M.J.   Sagalowsky A.I.   Belldegrun A.   Benson M.C.   Bihrle W.   Carroll P.R.   Ellis W.J.   Hudson M.A.   Sharkey F.E.  

Urology, Vol. 51, Iss. 2, 1998-02 ,pp. : 226-231

Elsevier

Access to resources Recommend Favorite

Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacille Calmette-Guerin: 18-year experience

By Pansadoro V.   Emiliozzi P.   de Paula F.   Scarpone P.   Pansadoro A.   Sternberg C.N.  

Urology, Vol. 59, Iss. 2, 2002-02 ,pp. : 227-231

Elsevier

Access to resources Recommend Favorite

Long-term maintenance bacille Calmette-Guerin therapy in high-grade superficial bladder cancer

By Iori F.   Di Seri M.   De Nunzio C.   Leonardo C.   Franco G.   Spalletta B.   Laurenti C.  

Urology, Vol. 59, Iss. 3, 2002-03 ,pp. : 414-418

Elsevier

Access to resources Recommend Favorite

Intravesical bacille Calmette–Guérin-induced multiorgan failure after treatment for transitional cell carcinoma

By Kiely Bridget   McLaughlin Anne Marie   Lynch Thomas H.   Keane Joseph  

Scandinavian Journal of Urology and Nephrology, Vol. 45, Iss. 4, 2011-09 ,pp. : 278-280

Informa Healthcare

Access to resources Recommend Favorite